Literature DB >> 28835241

Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.

Yuhei Hakozaki1, Shinichi Sameshima2, Teppei Tatsuoka1, Takashi Okuyama1, Yukinori Yamagata1, Tamaki Noie1, Masatoshi Oya1, Akiko Fujii3, Yoshihiko Ueda3, Chieko Shimura4, Kazumoto Katagiri4.   

Abstract

BACKGROUND: Neurofibromatosis type 1 (NF1) is an autosomally dominant inherited disorder characterized by multiple pigmented skin spots (café-au-lait spots) and neurofibroma. NF1 is associated with a wide variety of benign or malignant tumors. We report a NF1 patient who received surgical treatment for rectal carcinoma and multifocal small intestinal gastrointestinal stromal tumors (GISTs). CASE
PRESENTATION: A 70-year-old female patient with NF1 was referred to our hospital after a positive fecal occult blood test. Locally advanced rectal carcinoma was detected in the upper rectum using colonoscopy. A submucosal tumor 20 mm in diameter was detected in the duodenal bulb during the upper gastrointestinal endoscopy. The biopsy specimen from the duodenum was GIST with positive immunostaining of KIT and CD34 microscopically. Laparoscopic low anterior resection for rectal carcinoma and local excision of the duodenal GIST were performed successfully. During the operation, five white small nodules were found on the serosa of the jejunum. One nodule was excised for histological examination. The resected rectal tumor was a well-differentiated adenocarcinoma with multiple lymph nodes metastases according to the histology. The duodenal tumor was found to be low-risk GIST. Moreover, the nodule from the jejunum was very low risk GIST. An excised skin wart was neurofibroma according to the histology.
CONCLUSIONS: GIST or carcinomas have been reported to occasionally occur in the digestive tract of the patients with NF1. We present a rare case of a NF1 patient with GISTs and colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28835241      PMCID: PMC5569513          DOI: 10.1186/s12957-017-1231-3

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

Neurofibromatosis type 1 (NF1), also called Von Recklinghausen disease, is an autosomal dominant disorder characterized by multiple pigmented skin spots and neurofibromas. NF1 patients are predisposed to a wide variety of benign and malignant tumors. NF1 patients are also at increased risk of getting gastrointestinal stromal tumors (GISTs).

Case presentation

A 70-year-old female was referred to our hospital after a positive fecal occult blood test. The patient had hundreds of skin warts and pigmented spots on her body. None of her family had such skin lesions. Rectal carcinoma was detected in the upper rectum during colonoscopy (Fig. 1). Histological examination of a mucosal biopsy revealed well-differentiated adenocarcinoma. A submucosal tumor 20 mm in diameter was detected in the duodenal bulb during the preoperative screening upper gastrointestinal endoscopy (Fig. 2).
Fig. 1

Colonoscopy showing the locally advanced rectal carcinoma

Fig. 2

Submucosal tumor 20 mm in diameter detected in the duodenal bulb during the upper gastrointestinal endoscopy

Colonoscopy showing the locally advanced rectal carcinoma Submucosal tumor 20 mm in diameter detected in the duodenal bulb during the upper gastrointestinal endoscopy Histological examination of duodenal biopsy specimen showed spindle-shaped cells with positive immunohistochemical staining for KIT and CD34. S100 was negative for staining. The duodenal tumor was diagnosed as GIST. Abdominal-contrast CT showed the rectum wall and swelling of the lymph nodes in the mesorectum (Fig. 3). A duodenal tumor was found to protrude into the duodenal bulb (Fig. 4). Carcinoembryonic antigen (CEA) and carbohydrate antigen 19–9 (CA19-9) levels were within normal ranges.
Fig. 3

Pelvic contrast computed tomography (CT) scan showing wall thickening with contrast effect in the rectum and swelling of the lymph nodes

Fig. 4

A tumor with contrast effect found (on abdominal contrast CT scan) to protrude into the duodenal cavity

Pelvic contrast computed tomography (CT) scan showing wall thickening with contrast effect in the rectum and swelling of the lymph nodes A tumor with contrast effect found (on abdominal contrast CT scan) to protrude into the duodenal cavity Surgical exploration was undertaken and a diagnosis of rectal carcinoma with duodenal GIST was made. Laparoscopic low anterior resection with lymph nodes resection for the rectal carcinoma was performed followed by local resection of the duodenum with mini-laparotomy. During the operation, five white small nodules 3–6 mm in diameter were observed on the serosal surface of the jejunum approximately 20 cm from the Treiz ligament; one 6-mm nodule was excised for histological examination. A covering ileostomy was created, and one abdominal skin wart was excised for histological examination. The patient progressed favorably post operation and was discharged. Histologically, the resected rectal carcinoma was a well-differentiated adenocarcinoma with (four) lymph node metastasis (Fig. 5)—T2N2aM0 stage IIIB according to the TNM classification of UICC, seventh edition [1] (Fig. 7). The resected duodenal tumor was 22 mm in diameter and showed 1 mitosis per 50 high-power fields (HPF) microscopically (Fig. 6). Risk of tumor progression was low according to the modified-Fletcher classification [2]. A resected small nodule from the jejunum was also positive for KIT and CD34 immunohistochemically (Fig. 7a, b) but showed no mitosis per 50 HPF and the risk was very low. The resected skin wart was confirmed as neurofibroma after nodules showed proliferated spindle-shaped cells with unclear boundaries microscopically (Fig. 8).
Fig. 5

Well-differentiated adenocarcinoma of the rectum (× 200)

Fig. 7

GIST of the jejunum with no mitosis per 50 HPF (× 200). a Risk of tumor progression was very low. b Positive immunostaining of KIT

Fig. 6

GIST of the duodenum (× 200) with 1 mitosis per 50 high-power fields (HPF). Risk of tumor progression was low

Fig. 8

Neurofibroma of the skin (× 200)

Well-differentiated adenocarcinoma of the rectum (× 200) GIST of the duodenum (× 200) with 1 mitosis per 50 high-power fields (HPF). Risk of tumor progression was low GIST of the jejunum with no mitosis per 50 HPF (× 200). a Risk of tumor progression was very low. b Positive immunostaining of KIT Neurofibroma of the skin (× 200) The patient took adjuvant chemotherapy with capecitabine plus oxaliplatin [3]. However, it was discontinued after three courses due to severe diarrhea.

Discussion

NF1 is an autosomal dominant disorder characterized by multiple pigmented skin spots and neurofibroma. Among the general population, its estimated incidence is 1 in 3000 births [4]. An increased incidence of nervous system and non-nervous system tumors such as neurofibromas, malignant peripheral nerve sheath tumors, and gliomas has been reported in the general population [5, 6]. The frequency of malignancy in NF1 patients was reported to be higher than that expected in the general population. The development of NF1-associated tumors is largely explained by the underlying defect of the NF1 gene [7]. The NF1 protein (neurofibromin 1) negatively regulates RAS proteins through GTPase activity [8, 9]. Agaimy described gastrointestinal manifestations of NF1 [10]. They are true neurogenic neoplasms, interstitial cell of Cajal lesions such as GIST, neuroendocrine tumors, and adenocarcinomas. Neuroendocrine tumors arising in the ampullary or periampullary lesions are the most common and characteristic gastrointestinal manifestations of NF-1. GISTs reportedly occur occasionally in patients with NF1 [4, 11]. NF1-associated GISTs were reported as multiple generally low-grade tumors localized at the jejunum, ileum, duodenum, and stomach [12-14]. In our case, the risk of GISTs was low grade in the duodenum and very low grade in the jejunum. The co-existence of a duodenal somatostatinoma and GISTs in a patient with NF1 represents a typical and almost pathognomonic feature of NF-1 [15]. In our case, neuroendocrine neoplasms were not associated. There have been a few reports of colorectal carcinomas arising in NF1 patients. Zoller reported that how 17 of 70 NF1 patients had developed a total of 19 malignant tumors in Sweden; 4 cases of colorectal carcinoma were included [16]. Kim also reported a case of colon carcinoma in 125 Korean NF1 patients [17]. A case of synchronous multiple colon adenocarcinomas in a patient with NF1 was also reported [18]. In our case, the NF1 patient had multiple GISTs and rectal carcinoma. Apart from a few Japanese reports, no other reports in the worldwide literature have mentioned a NF1 patient with both GIST and colorectal carcinoma. It is unclear whether this colorectal carcinoma is related to the NF1 mutation or whether it is a sporadic carcinoma. The association between NF1 and adenocarcinoma of the gastrointestinal tract is thought to be casual. Negative regulation of RAS protein by neurofibromin 1 may affect the carcinogenesis of the rectal carcinoma [19]. Li reported that the germline mutations in NF1 that cause NF1 can also occur in somatic cells and contribute to the cancer development [20]. In this case, the tumor progression risks of GISTs were low in the duodenum and very low in the jejunum. Unresected small nodules of the jejunum will not affect the prognosis of the patient. The resected rectal carcinoma was locally advanced (stage IIIB). The prognosis of this patient is dependent on the relapse of the rectal carcinoma and a scheduled examination to evaluate any recurrence is required.

Conclusions

In summary we presented a rare case of NF1 patient associated with multiple GISTs and rectal carcinoma.
  19 in total

1.  NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics.

Authors:  Johanna Andersson; Harri Sihto; Jeanne M Meis-Kindblom; Heikki Joensuu; Nina Nupponen; Lars-Gunnar Kindblom
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

2.  Von Recklinghausen's disease: a clinicopathological study.

Authors:  R D Brasfield; T K Das Gupta
Journal:  Ann Surg       Date:  1972-01       Impact factor: 12.969

3.  Somatic mutations in the neurofibromatosis 1 gene in human tumors.

Authors:  Y Li; G Bollag; R Clark; J Stevens; L Conroy; D Fults; K Ward; E Friedman; W Samowitz; M Robertson
Journal:  Cell       Date:  1992-04-17       Impact factor: 41.582

4.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Authors:  D G R Evans; M E Baser; J McGaughran; S Sharif; E Howard; A Moran
Journal:  J Med Genet       Date:  2002-05       Impact factor: 6.318

5.  Oncologic manifestations of neurofibromatosis type 1 in Korea.

Authors:  Eui Tae Kim; Hwan Namgung; Hyun Deok Shin; Soon Il Lee; Jee Eun Kwon; Myung Chul Chang; Dong Guk Park
Journal:  J Korean Surg Soc       Date:  2012-03-27

6.  Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.

Authors:  Hans-Joachim Schmoll; Josep Tabernero; Jean Maroun; Filippo de Braud; Timothy Price; Eric Van Cutsem; Mark Hill; Silke Hoersch; Karen Rittweger; Daniel G Haller
Journal:  J Clin Oncol       Date:  2015-08-31       Impact factor: 44.544

7.  Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.

Authors:  Yasuko Hirata; Hilde Brems; Mayu Suzuki; Mitsuhiro Kanamori; Masahiro Okada; Rimpei Morita; Isabel Llano-Rivas; Toyoyuki Ose; Ludwine Messiaen; Eric Legius; Akihiko Yoshimura
Journal:  J Biol Chem       Date:  2015-12-03       Impact factor: 5.157

Review 8.  Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations.

Authors:  Abbas Agaimy; Nikolaos Vassos; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2012-10-20

Review 9.  Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1.

Authors:  Hilde Brems; Eline Beert; Thomy de Ravel; Eric Legius
Journal:  Lancet Oncol       Date:  2009-05       Impact factor: 41.316

Review 10.  Gastrointestinal stromal tumors associated with neurofibromatosis 1: a single centre experience and systematic review of the literature including 252 cases.

Authors:  Pier Federico Salvi; Laura Lorenzon; Salvatore Caterino; Laura Antolino; Maria Serena Antonelli; Genoveffa Balducci
Journal:  Int J Surg Oncol       Date:  2013-12-09
View more
  6 in total

1.  A Huge Pelvic-Abdominal Malignant GIST Tumour in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review.

Authors:  Islam Omar; Hani Alsaati; Ejaz Waris
Journal:  Case Rep Oncol Med       Date:  2020-01-04

2.  Laparoscopic retroperitoneal resection of the duodenal gastrointestinal stromal tumors in neurofibromatosis type 1; Case Report and literature review.

Authors:  Al-Danakh Abdullah; Safi Mohammed; Mohammed Alradhi; Xinqing Zhu; Deyong Yang
Journal:  Front Surg       Date:  2022-08-26

3.  Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review.

Authors:  Georgi Popivanov; Mihail Tabakov; George Mantese; Roberto Cirocchi; Irene Piccinini; Vito D'Andrea; Piero Covarelli; Carlo Boselli; Francesco Barberini; Renata Tabola; Ursi Pietro; Davide Cavaliere
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-21

4.  Gastrointestinal Stromal Tumors with KIT Mutation Coexisting with Wild-type Gastrointestinal Stromal Tumors in a Patient with Neurofibromatosis Type 1.

Authors:  Yang Li; Zhi-Dong Gao; Xiao-Dong Yang; Ying-Jiang Ye; Shan Wang; Ke-Wei Jiang
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

5.  A Unique Coexistence of Rectal Adenocarcinoma and Gastric Antral Gastrointestinal Stromal Tumor: A Case Report and Minireview.

Authors:  Mahmoud Rezk-Abdelwahed Hussein; Abdullah Saad Alqahtani; Ahmed Mostafa Mohamed; Yahia Ibraheem Assiri; Nasser Ibraheem Alqahtani; Saeed Ali Alqahtani; Hatim Mahgoub Ali; Asim Abdallah Ahmed Elyas; Mubarak Mohammed Al-Shraim; Syed Shamshad Hussain; Eman E Abu-Dief
Journal:  Gastroenterology Res       Date:  2021-12-13

6.  Recurrent NF1 gene variants and their genotype/phenotype correlations in patients with Neurofibromatosis type I.

Authors:  Matteo Riva; Davide Martorana; Vera Uliana; Edoardo Caleffi; Elena Boschi; Livia Garavelli; Giovanni Ponti; Luca Sangiorgi; Claudio Graziano; Stefania Bigoni; Luca Maria Rocchetti; Simona Madeo; Fiorenza Soli; Enrico Grosso; Diana Carli; Matteo Goldoni; Francesco Pisani; Antonio Percesepe
Journal:  Genes Chromosomes Cancer       Date:  2021-09-03       Impact factor: 4.263

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.